[1] Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria[J]. Allergy, 2018, 73(7):1393-1414.
[2] Jonathan A, Bernstein M, David M, et al. The diagnosis and management of acute and chronic urticaria: 2014 update [J]. J Allergy Clin Immunol, 2014, 133(5):1270-1277.
[3] Chang T W, Chen C, Lin C J, et al. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticarial [J]. J Allergy Clin Immunol,2015, 135(2):337-342.
[4] Reichrath J, Zouboulis C C, Vogt T, et al. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: an historical view and outlook[J]. Rev Endocr Metab Disord, 2016, 17(3): 405-417.
[5] 张明君,杨继红.维生素D的新认识[J].中国全科医学,2018,21(20):2395-2399.
[6] Jiang W, Wu D B. An epidemiology survey of vitamin D deficiency and its influencing factors [J]. Med Clin (Barc), 2019, in press.
[7] Juliana K, Andrea S, Mario F. Vitamin D every day to keep the infection away[J]. Nutrients, 2015, 7(6): 4170-4188.
[8] Grzanka A, Machura E, Mazur B, et al. Relationship between vitamin D status and the inflammatory state in patients with chronic spontaneous urticaria[J]. J Inflamm, 2014, 11(1): 2.
[9] Souberbielle J C. Epidemiology of vitamin-D deficiency [J]. Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement, 2016, 14(1):7-15.
[10] Munger K L, Levin L I, Hollis B W, et al. Serum 25-hydroxyvitamin d levels and risk of multiple sclerosis[J]. JAMA, 2006, 296(23): 2832-2838.
[11] Pinto R D, Pietropaoli D, Chandar A K, et al. Association between inflammatory bowel disease and vitamin D deficiency: a systematic review and Meta-analysis.[J]. Inflamm Bowel Dis, 2015, 21(11): 2708-2717.
[12] Karagün E, Can E, Sevim B, et al. The role of serum vitamin D levels in vitiligo[J]. Postepy Dermatol Alergol, 2016, 33(4):300-302.
[13] Yao C A. Serum vitamin D level and disease severity of alopecia areata: a meta-regression analysis[J]. J Am Acad Dermatol, 2018, 79(3): e49-e50.
[14] 沈萃萃, 吕 萌. 慢性荨麻疹患者血清25羟基维生素D水平变化及其与Th1/Th2细胞失衡的关系[J]. 山东医药, 2018, 58(4):77-79.
[15] Lemire J M, Archer D C, Beck L,et al. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions[J]. J Nutr, 1995, 125(6 Suppl):1704S-1708S.
[16] 王亚婷,石春蕊,武 奕,等. 慢性自发性荨麻疹患者外周血Treg细胞比例和白细胞介素17A、27水平及意义[J]. 中华皮肤科杂志, 2017, 50(12):916-919.
[17] Chang S H, Chung Y, Dong C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression[J]. J Biol Chem, 2010, 285(50):38751-38755.
[18] Cousens L P, Najafian N, Mingozzi F, et al. In vitro and in vivo studies of IgG-derived treg epitopes (tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity[J]. J Clinl Immunol, 2013, 33(1 Supplement):43-49.
[19] Arshi S, Babaie D, Nabavi M, et al. Circulating level of CD4⁺ CD25⁺ FOXP3⁺ T cells in patients with chronic urticaria [J]. Int J Dermatol, 2015, 53(12):e561-e566.
[20] Luciano A, Giuseppe P. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists[J]. Hum Immunol, 2009, 70(5):345-352.
[21] Tavakol M, Movahedi M, Amirzargar A A, et al. Association of interleukin 10 and transforming growth factor β gene polymorphisms with chronic idiopathic urticaria[J]. Acta Dermatovenerol Croat, 2014, 22(4): 239-45.
[22] Xie Y H, Li X P, Xu Z X, et al. Effect of compound Maqin decoction on TGF-1/Smad proteins and IL-10 and IL-17 content in lung tissue of asthmatic rats[J]. Genet Mol Res, 2016, 15(3): 234-237.
[23] 刘军连,徐冰心,王晓菲,等.自身免疫性慢性荨麻疹患者外周血单个核细胞TLR2的表达及意义[J].中国皮肤性病学杂志, 2015, 29(7): 681-683.
[24] Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns[J]. Eur J Immunol, 2006, 36(2): 361-370.
[25] Wang S F, Gao X Q, Xu Y N, et al. Elevated plasma level of interferon-λ1 in chronic spontaneous urticaria: upregulated expression in CD8(+) and epithelial cells and induction of inflammatory cell accumulation[J]. Mediators Inflamm, 2016, 15(3): 20-51.
[26] 张明海,戴前梅. 慢性荨麻疹患者外周血白细胞介素9和转录因子PU.1的表达及意义[J].中华皮肤科杂志,2015, 48(2):108-111.
[27] Benson A A, Toh J A, Vernon N,et al. The role of vitamin D in the immunopathogenesis of allergic skin diseases[J]. Allergy, 2012, 67(3):296-301.
[28] Mohammed J, Gunderson A J, Khong H H, et al. TGFβ1 overexpression by keratinocytes alters skin dendritic cell homeostasis and enhances contact hypersensitivity[J]. J Invest Dermatol, 2013, 133(1): 135-143.
[29] 平杰丹. 荨麻疹血清蛋白分析及维生素D在其发病过程中的作用[D]. 郑州:郑州大学,2019.
[30] Church M K, Kolkhir P, Metz M, et al. The role and relevance of mast cells in urticaria[J]. Immunol Rev, 2018, 282(1):232-247.
[31] Boonpiyathad T, Pradubpongsa P, Sangasapaviriya A. Vitamin D supplements improve urticaria symptoms and quality of life in chronic spontaneous urticaria patients: a prospective case-control study[J]. Derm Endocrinol, 2016, 8(1): e983685.
[32] Chandrashekar L, Rajappa M, Munisamy M, et al. 25-Hydroxy vitamin D levels in chronic urticaria and its correlation with disease severity from a tertiary care centre in South India[J]. Clin Chem Lab Med, 2014, 52(6): E115-E118.
[33] Thorp W A, Goldner W, Meza J, et al. Reduced vitamin D levels in adult subjects with chronic urticaria[J]. J Allergy Clin Immunol, 2010, 126(2):413-414.
[34] Rasool R, Masoodi K Z, Shera I A, et al. Chronic urticaria merits serum vitamin D evaluation and supplementation;a randomized case control study[J]. World Allergy Organ J, 2015, 8(1): 15.
[35] Topal I O, Goncu O E, Gungor S, et al. Does replacement of vitamin D reduce the symptom scores and improve quality of life in patients with chronic urticaria[J]. J Dermatol Treat, 2015, 27(2):1-19.